Uploaded July 2026 | Updated September 2026, 3 days ago

---

Artificial intelligence is becoming an increasingly important part of diabetes care but is it ready for everyday clinical practice?

In this discussion from the 61st EASD Annual Meeting, Vivienne Parry is joined by Prof. João Filipe Raposo (Portugal) and Prof. Harald Sourij (Austria) to debate both the opportunities and challenges of AI in diabetes.

The conversation explores:
• How AI supports automated insulin delivery and continuous glucose monitoring (CGM)
• Personalising diabetes treatment using large datasets
• Predicting cardiovascular risk and diabetes outcomes
• The evidence needed before widespread clinical adoption
• Data quality, privacy and regulatory challenges
• Why empathy and patient-centred care remain essential alongside AI

Can AI improve outcomes for people living with diabetes, or should healthcare systems proceed more cautiously? Watch to hear both perspectives.

Subscribe for more content from EASD TV.